Clinical Microbiology and Infection

Article	Citations
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness	767
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia	746
Outside Front Cover	464
COVID-19 in special populations	441
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition	214
‘Scope and aims of ESCMID guidelines’ by Scudeller et al.	182
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi	177
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response	166
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20	161
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use	145
Re: ‘Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicentre study in France, 2008–2019’ by Leroux et al.	130
Exploring the limits of interferon-γ releasing assay screening in large-scale populations	124
Limitations of genomic surveillance: a Clostridioides difficile case study in the Netherlands	115
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?	114
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study	112
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?	107
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models	105
Optimizing antifungal therapies for Candida infections: evidence, resistance, and emerging approaches	104
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections	103
Optimising the management of invasive candidiasis	101
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	97
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis	93
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023	91
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples	89
The importance of patient information and informed consent for unlicensed phage therapy	88

A randomized trial of simultaneous versus sequential pneumococcal vaccination in elderly	82
Re: ‘Dosing and route of administration of clindamycin given in combination with rifampicin’ by Magreault et al.	82
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)	82
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern	81
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments	80
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing	77
Large language models for antibiotic prescribing—moving the needle from ‘parlour trick’ to practical tool	75
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate	75
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	75
The interplay between Epstein-Barr virus and cytomegalovirus reactivation following allogeneic haematopoietic cell transplantation in the era of primary cytomegalovirus prophylaxis	71
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation	71
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections	69
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study	67
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)	66
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021	64
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	63
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?	63
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review	62
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?	62
Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019–2023	61
Diagnostic accuracy of self-collected tongue swabs for Mycobacterium tuberculosis complex detection in individuals being assessed for tuberculosis in South Africa using the Xpert MTB/RIF Ultra assay	60
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women—a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)	60
The hidden link between cefiderocol resistance and increased virulence in Klebsiella pneumoniae: Insights from a TraDIS-based investigation	60
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values	60
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19	58
Laboratory innovations to diagnose invasive mould infections—what is relevant, what is not?	58
Inferring antibiotic susceptibility from metagenomic data: dream or reality?	58
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial	58
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study	58
Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects	57
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China	57
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?	56
Kinetics of the Alethia® malaria loop-mediated isothermal amplification (LAMP) positivity during post-treatment follow-up of patients with imported malaria	55
Steroids for viral meningitis: a foe or a friend?	54
Optimization of antiviral dosing in Herpesviridae encephalitis: a promising approach to improve outcome?	53
One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis	50
The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?	49
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women	49
Scope and aims of European society of clinical microbiology and infectious diseases guidelines: a white paper	48
Effect of a multimodal prevention strategy on dialysis-associated infection events in outpatients receiving haemodialysis: The DIPS stepped wedge, cluster-randomized trial	47
Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model	47
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa	46
Which trials do we need?	46
Uncovering hidden transmission pathways of Klebsiella pneumoniae: is there a need to re-evaluate the necessity for toilet disinfection?	46
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients	45
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents	44
Assessing prescription of antibiotics after vaccination against pneumococcal pneumonia; using prescription sequence symmetry analysis	43
Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations	43
Evaluating the lockdown-induced effect on respiratory viruses in blood donors during two COVID-19 waves: a retrospective cross-sectional observational study in Denmark	43
Unexpected natural cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic background	42

Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns	42
Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients	42
Re: ‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’ by Kim et al.	41
A chronic infectious bladder stone causing an obstructive emphysematous cystitis	41
Remdesivir for the treatment of COVID-19: author's response	41
A comparative evaluation of commercial boric acid containers for preserving microorganisms in urine specimens	41
Seeing is Believing	41
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies	40
Alternative therapies against Mycobacterium abscessus infections	40
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia	40
A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection	40
A strain uncoloured by Gram staining in a pleural fluid	40
The controversial bond between COVID-19 and bacterial superinfections	39
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia	39
The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort	39
Accuracy of cholera rapid diagnostic tests: a systematic review and meta-analysis	38
Community adoption of protective behaviours: before and during the COVID-19 pandemic	37
Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up	37
In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection	37
The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid	36
Effect of antiseptic bathing with chlorhexidine or octenidine on central line–associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial	36
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial	36
Removal of incorrect penicillin allergy labels in a UK hospital	36
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection	35
Assessing the accuracy of a novel algorithm for group B Streptococcus detection in pregnant women and its impact on early-onset neonatal group B streptococcal infections	35
‘Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA COVID-19 vaccine compared to unexposed infants’ – author's response	35
How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factors	35
Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission	35
Early switch to oral antimicrobials in brain abscess: a narrative review	35
Blood culture bottles remain efficient months after their expiration date: implications for low- and middle-income countries	35
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort	34
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard	34
An overview of COVID-19 in solid organ transplantation	34
Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines	34
Re: ‘ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults’ by Bodilsen et al.	34
High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: a prospective multisite cross-sectional study (ANRS COV11)	34
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!	34
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply	33
Predictors of laboratory-confirmed mpox in people with mpox-like illness	33
Decision letters from other journals	33
Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic	33
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024	32
An introduction to network meta-analyses in clinical microbiology and infectious diseases	32
Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States	32
Exploring the dynamics of Borrelia burgdorferi sensu lato antibodies—a registry-based study on laboratory data from Sweden and Denmark	32
Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study	32
Changing face of mpox	32
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort	31
Late positivization of oropharyngeal, plasma, anal, semen, and urine specimens which tested negative at the time of mpox diagnosis	31
How to use direct microscopy for diagnosing fungal infections	31
Why don't we talk about tuberculosis stewardship?	31
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance	31
Using a difficult-to-treat resistance index to gauge imbalance between countries' antibiotic resistance prevalence and access to antibiotics: a scoping review and concept proposal	31
Lyme neuroborreliosis with encephalitis; a systematic literature review and a Scandinavian cohort study	30
Rice bodies in Brucellar tenosynovitis	30
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19	30
Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis	30
Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates	30
Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations	30
Are we enrolling the right patients? A scoping review of external validity and generalizability of clinical trials in bloodstream infections	30
Which trial do we need? Corticosteroid therapy in Lyme borreliosis–associated facial palsy: a double-blind placebo-controlled multicentre randomized trial	30
Diagnostic test accuracy of the Fungitell serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	30
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort study	29
Real-life validation of a sample pooling strategy for screening of hepatitis C	29
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group	29
Availability and costs of medicines for the treatment of tuberculosis in Europe	29
Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic	29
New drugs, old problems: a narrative review of antibiotic stewardship programme in the era of novel gram-negative antibiotics	29
A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages	29
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	28
Revisiting diagnostics: practical application of next-generation sequencing technologies for infectious diseases	28
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease	28
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility	28
Establishing piperacillin–tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurement	27
Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settin	27
Relative contributions of the ERG11VF125AL and MRR1AN647T mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates	27
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	27
Long-term evolution of humoral immune response after SARS-CoV-2 infection	26
Ceftaroline for methicillin-resistant Staphylococcus aureus bacteraemia: a magic bullet, a weight on the seesaw, or neither?	26
Re: predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19	26

Determining the effect of pneumococcal vaccination on antibiotic prescriptions: is prescription sequence symmetry analysis a valid approach?	26
Integrating pre-test probability and β-D-glucan cut-offs to enhance accuracy in diagnosing pneumocystis pneumonia	26
Sepsis: a summary of the SEP-1 quality measure and future considerations	26
Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden	26
Escherichia coli community-acquired meningitis in adults: a case series of 29 patients in France	26
Mortality and sequelae associated with regional use of intracranial devices among patients with pneumococcal meningitis: a nationwide, population-based cohort study	26
Re: ‘Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland’ by Garzoni et al.	26
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian m	26
Re: ‘Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients’ by Cornely et al.	26
Seeing the whole elephant: designing ‘one health’ governance to fight antimicrobial resistance	26
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study	25
ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata	25
Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection	25
Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation	25
COVID-19 vaccine: missed opportunities and hospital vaccine implementation	25
Pleural aspergillosis in an otherwise healthy patient diagnosed by medical thoracoscopy	25
Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China	25
A contemporary review of clade-specific virological differences in monkeypox viruses	25
First-generation oral antivirals against SARS-CoV-2	25
Clinical characteristics and outcomes of Bordetella parapertussis compared with Bordetella pertussis: a retrospective observational study	25
Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules	25
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial	25
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system	25
Unneeded antibiotics for acute respiratory infections in primary care: stop as early as possible	24
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	24
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients	24
The challenge to improving and standardizing training in infectious diseases in Europe	24
Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females	24
Target trial emulation framework: mitigating methodological challenges and application in COVID-19 treatment evaluation studies	24
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis	24
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	24
Bacteriophage therapy in humans	24
Management of Gram-positive multiresistant bacteria prosthetic joint infection: a narrative review on current and innovative strategies	24
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 stud	24
How To: The Application and Analysis of Categorical Agreement in Antimicrobial Susceptibility Testing using EUCAST Breakpoints	24
Re: ‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 infection in older Singaporeans’ by Wee et al.	24
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection	24
Enhancing antimicrobial stewardship: recommendations to support implementation of the 2024 UN General Assembly political declaration on antimicrobial resistance	23
Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study	23
Factors associated with the appropriateness of antibiotics prescribed in French general practice: a cross-sectional study using reimbursement databases	23
Factors associated with the detection of norovirus among asymptomatic adults	23
Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection	23
Septic pubic symphysitis: newest radiological, microbiological, and outcome findings in a rare and difficult-to-treat infection	23
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme	23
Decision letter from other journals and peer review	22
Safeguarding COVID-19 vaccines: establishing the safety of novel vaccine platforms	22
Corrigendum to “Does SARS-CoV-2 re-infection depend on virus variant?” [Clin Microbiol Infect 27 (9) (2021 Sep) 1374–1375]	22
Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes	22
Borrelia mayonii – A cause of Lyme borreliosis that can be visualized by microscopy of thin blood films	22
Executive Committee	22
Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis	22
Antibiotic resistance in Türkiye: what has been done and what needs to be done urgently?	22
Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: author's response	22
Corrigendum to “Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model” [Clin Microbiol Infect 29 (12) (2023) P1600.e1–1600.e6]	22
Early and better diagnosis for Lyme neuroborreliosis	21
The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study	21
Comparative epidemiology of diarrhoeal organisms in high-risk adults using multiplex PCR gastrointestinal panel testing: a multicentre observational study	21
Re: ‘Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard’ by Salzer et al.	21
Refocus attention on HIV/AIDS: due to neglect during the COVID-19 pandemic	21
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains	21
Case-fatality rate of invasive pneumococcal disease caused by various serotypes—an analysis of nationwide surveillance data from Israel, 2009–2018	21
Co-administration of COVID-19 and influenza vaccines	21
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series	21
Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis	21
Association of time to positivity with disease severity in bloodstream infections—a population-based cohort study	21
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's response	21
Passive surveillance of Powassan virus in human-biting ticks and health outcomes of associated bite victims	21
Massive furunculoid myiasis in a traveller after a trip to Uganda	21
Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled	20
Human alveolar echinococcosis–global, regional, and national annual incidence and prevalence rates	20
HlyF, an underestimated virulence factor of uropathogenic Escherichia coli	20
Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization	20
Confront cholera crisis after the Myanmar earthquake	20
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review	20
Sore throat-related infections – lessons learnt from non-pharmacological interventions and non-COVID-19 infections	20
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data	20
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up	20
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply	20
The case for the access, watch, and reserve (AWaRe) universal guidelines for antibiotic use	19
Revisiting diagnostics: multiplex PCR system for rapid diagnosis of respiratory virus infections: can we do better?	19
Pre-emptive approach against toxoplasmosis in allogeneic haematopoietic cell transplantation. Still far away from experience in CMV	19
A world health assembly resolution on diagnostics: implications for the ESCMID community	19
Mass screening strategy for the SARS-CoV-2 Delta variant outbreak in Guangzhou, May 2021	19
Thank you to our peer-reviewers: CMI 2023	19
Disseminated Saccharomyces cerevisiae infection in advanced HIV: a literature review	19
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales	19
Evaluating the use of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the workup of Staphylococcus aureus bacteraemia: a cost-utility analysis	19
Duration of immunity after inactivated poliovirus vaccine: how many booster doses are needed?	19
Revisiting diagnosis: culture smarter, not harder: role of enrichment broth cultures in microbiology	19
Reprint of: From medical editors: a call to the global infectious diseases and clinical microbiology community	19
An unusual paediatric case of post–kala-azar dermal leishmaniasis: a hidden parasite under the veil of white	19
Synthesizing pathogen- and infection-specific estimates of the burden of antimicrobial resistance in Europe for health-technology assessment: gaps, heterogeneity, and bias	19
Caring for older adults during the COVID-19 pandemic	18
Modifiable and nonmodifiable risk factors for non-ventilator-associated hospital-acquired pneumonia identified in a retrospective cohort study	18
Re: ‘Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia’ by Kritsotakis et al.	18